We're not going to allow Medicare anymore. And the third big ask is to governors. If you can hear my voice now, please listen carefully. Medicaid monies spent on these biosimilars will dramatically reduce the cost that states have to shoulder for Medicaid. That allows Medicaid to exist healthily with access to all the medications that can be life saving and life changing at the same time. Not crowd out education and other social services. (22:40–22:49)
CLAIM
Asserts that spending Medicaid funds on biosimilars will reduce state costs for Medicaid.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
